scholarly article | Q13442814 |
P356 | DOI | 10.1080/09205063.2014.938979 |
P698 | PubMed publication ID | 25040893 |
P50 | author | Takuro Niidome | Q42807839 |
P2093 | author name string | Kazuto Watanabe | |
Takeshi Mori | |||
Yoshiki Katayama | |||
Kayo Takahashi | |||
Kenshiro Naoyama | |||
Hisayo Yamauchi | |||
P2860 | cites work | Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors | Q39653208 |
Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin | Q40025224 | ||
Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration | Q40310715 | ||
Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models. | Q40368363 | ||
Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. | Q40453716 | ||
Liposomal doxorubicin (Caelyx) in symptomatic androgen-independent prostate cancer (AIPC)--delayed response and flare phenomenon should be considered | Q40641342 | ||
Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method? | Q43238303 | ||
A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems. | Q43963775 | ||
In vitro gene transfection using dendritic poly(L-lysine). | Q43992769 | ||
Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity | Q29614981 | ||
Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style | Q33514578 | ||
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. | Q33732629 | ||
Dendrimers in drug research | Q34291645 | ||
Designing dendrimers for biological applications | Q34473653 | ||
Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo | Q34635753 | ||
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas | Q35130646 | ||
Dendrimers and dendritic polymers in drug delivery | Q36022312 | ||
Dendrimer-drug interactions. | Q36323316 | ||
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer. | Q36671058 | ||
Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells. | Q36853778 | ||
Nanoparticles for tumor targeted therapies and their pharmacokinetics | Q37722776 | ||
Targeting nanoparticles to cancer. | Q37728139 | ||
Doxorubicin-conjugated dendrimer/collagen hybrid gels for metastasis-associated drug delivery systems | Q39242370 | ||
Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models | Q39414448 | ||
Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. | Q39593858 | ||
P433 | issue | 13 | |
P921 | main subject | doxorubicin | Q18936 |
hydrophobicity | Q41854968 | ||
P304 | page(s) | 1362-1373 | |
P577 | publication date | 2014-07-21 | |
P1433 | published in | Journal of Biomaterials Science. Polymer Edition | Q15760949 |
P1476 | title | Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine) | |
P478 | volume | 25 |
Q38755622 | Dendrimer-mediated approaches for the treatment of brain tumor. |
Q41734074 | Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. |
Q38779839 | Peptide-Decorated Dendrimers and Their Bioapplications |
Q28085438 | Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery |
Search more.